These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3042268)

  • 1. Effect of pentoxifylline and its metabolites on three theophylline assays.
    Cohen IA; Johnson CE; Wesolowicz L; Converse-Swastek K
    Clin Pharm; 1988 Jun; 7(6):457-61. PubMed ID: 3042268
    [No Abstract]   [Full Text] [Related]  

  • 2. Interference potential of pentoxifylline and its major metabolite with theophylline assays.
    Cummings DM; Rocci ML; Green P; Saccar C
    Am J Hosp Pharm; 1985 Dec; 42(12):2717-8. PubMed ID: 3909811
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of theophylline assay interference from pentoxifylline and its metabolites.
    Morton MR; Parish RC; Spruill WJ
    Ther Drug Monit; 1989; 11(3):347-8. PubMed ID: 2728093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of pentoxifylline and its hydroxy metabolite in human plasma.
    Garnier-Moiroux A; Poirier JM; Cheymol G; Jaillon P
    J Chromatogr; 1987 Apr; 416(1):183-8. PubMed ID: 3597635
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
    Kwong EC; Chen FC; Young LM
    Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of pentoxifylline and its hydroxy metabolite in plasma by high-performance liquid chromatography.
    Chivers DA; Birkett DJ; Miners JO
    J Chromatogr; 1981 Sep; 225(1):261-5. PubMed ID: 7298755
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5'-hydroxyhexyl)xanthine, by high-performance liquid chromatography.
    Luke DR; Rocci ML
    J Chromatogr; 1986 Jan; 374(1):191-5. PubMed ID: 3949928
    [No Abstract]   [Full Text] [Related]  

  • 8. High-performance liquid chromatographic analysis of pentoxifylline and 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine in whole blood.
    Grasela DM; Rocci ML
    J Chromatogr; 1987 Aug; 419():368-74. PubMed ID: 3667793
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of pentoxifylline and its 5-hydroxy metabolite in human plasma by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Musch G; Hamoir T; Massart DL
    J Chromatogr; 1989 Oct; 495():215-26. PubMed ID: 2613806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (pentoxifylline) and its 3,7-dimethyl-1-(5-hydroxyhexyl)-xanthine metabolite in the plasma of patients with multiple diseases using high-performance liquid chromatography.
    Rieck W; Platt D
    J Chromatogr; 1984 Feb; 305(2):419-27. PubMed ID: 6707169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of pentoxifylline during concomitant theophylline administration to rats.
    Rocci ML; Luke DR; Saccar CL
    Pharm Res; 1987 Oct; 4(5):433-5. PubMed ID: 3508555
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers.
    Morimoto T; Kotegawa T; Tsutsumi K; Ohtani Y; Imai H; Nakano S
    J Clin Pharmacol; 2004 Jan; 44(1):95-101. PubMed ID: 14681347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The excretion of pentoxifylline and its metabolites into human breast milk.
    Witter FR; Smith RV
    Am J Obstet Gynecol; 1985 Apr; 151(8):1094-7. PubMed ID: 3985069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects.
    Raz I; Ben-David J; Hussein Z; Samara E
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):206-8. PubMed ID: 3403100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 16. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.
    Zandvliet AS; Huitema AD; de Jonge ME; den Hoed R; Sparidans RW; Hendriks VM; van den Brink W; van Ree JM; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):71-9. PubMed ID: 15667599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of pentoxifylline and its major metabolites in microbial extracts by thin-layer and high-performance liquid chromatography.
    Smith RV; Yang SK; Davis PJ; Bauza MT
    J Chromatogr; 1983 Dec; 281():281-7. PubMed ID: 6668334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of oxpentifylline and three metabolites in plasma by automated capillary gas chromatography using nitrogen-selective detection.
    Burrows JL
    J Chromatogr; 1987 Dec; 423():139-46. PubMed ID: 3443643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.
    Peck K; Mealey KL; Matthews NS; Taylor TS
    Am J Vet Res; 1997 Aug; 58(8):881-4. PubMed ID: 9256975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.